<SEC-DOCUMENT>0001171843-25-000470.txt : 20250128
<SEC-HEADER>0001171843-25-000470.hdr.sgml : 20250128
<ACCEPTANCE-DATETIME>20250128160243
ACCESSION NUMBER:		0001171843-25-000470
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250128

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brainsway Ltd.
		CENTRAL INDEX KEY:			0001505065
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90993
		FILM NUMBER:		25564074

	BUSINESS ADDRESS:	
		STREET 1:		19 HARTUM STREET, BYNET BUILDING, 3RD FL
		STREET 2:		Har HaHotzvim
		CITY:			Jerusalem
		STATE:			L3
		ZIP:			91451
		BUSINESS PHONE:		972 2 581-3140

	MAIL ADDRESS:	
		STREET 1:		19 HARTUM STREET, BYNET BUILDING, 3RD FL
		STREET 2:		Har HaHotzvim
		CITY:			Jerusalem
		STATE:			L3
		ZIP:			91451

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hagai Avner
		CENTRAL INDEX KEY:			0001956362
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		SHAKHAL ST 65
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9372106
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001171843-22-007748</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Hagai Avner -->
          <cik>0001956362</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Ordinary Shares, par value NIS 0.04 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>01/28/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001505065</issuerCik>
        <issuerName>BRAINSWAY LTD.</issuerName>
        <issuerCusip>10501L106</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>19 Hartum Street</com:street1>
          <com:street2>Bynet Building, 1st floor, Har Hotzvim</com:street2>
          <com:city>Jerusalem</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>91451</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Avner Hagai</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>L3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1772351.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1772351.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1772351.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.71</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(a) Following sales occurring between November 20, 2024 and December 10, 2024.

(b) Based on 37,632,302 Ordinary Shares outstanding as of January 26, 2025 (as received from the Company).</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>BRAINSWAY LTD.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>16 Hartum Street, RAD Tower 14th Floor, Jerusalem 9777516, Israel</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Avner Hagai</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of Avner Hagai is Shakhal St 65, Jerusalem, 93721, Israel.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Israeli</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See row 9 of cover page.</amountBeneficiallyOwned>
        <classPercent>See row 11 of cover page.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See row 5 of cover page.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See row 6 of cover page.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See row 7 of cover page.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See row 8 of cover page.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Avner Hagai</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Avner Hagai</signature>
        <title>Avner Hagai</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
